AxoGen Price to Book Ratio 2012-2025 | AXGN
Historical price to book ratio values for AxoGen (AXGN) over the last 10 years. The current price to book ratio for AxoGen as of February 12, 2026 is 12.94.
| AxoGen Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-12 | 32.61 | 12.45 | |
| 2025-09-30 | 17.84 | $2.62 | 6.81 |
| 2025-06-30 | 10.85 | $2.45 | 4.42 |
| 2025-03-31 | 18.50 | $2.32 | 7.99 |
| 2024-12-31 | 16.48 | $2.35 | 7.00 |
| 2024-09-30 | 14.02 | $2.26 | 6.21 |
| 2024-06-30 | 7.24 | $2.18 | 3.32 |
| 2024-03-31 | 8.07 | $2.13 | 3.78 |
| 2023-12-31 | 6.83 | $2.22 | 3.08 |
| 2023-09-30 | 5.00 | $2.27 | 2.20 |
| 2023-06-30 | 9.13 | $2.26 | 4.04 |
| 2023-03-31 | 9.45 | $2.28 | 4.15 |
| 2022-12-31 | 9.98 | $2.38 | 4.19 |
| 2022-09-30 | 11.92 | $2.40 | 4.97 |
| 2022-06-30 | 8.19 | $2.41 | 3.39 |
| 2022-03-31 | 7.94 | $2.47 | 3.21 |
| 2021-12-31 | 9.37 | $2.70 | 3.47 |
| 2021-09-30 | 15.80 | $2.77 | 5.70 |
| 2021-06-30 | 21.61 | $2.87 | 7.53 |
| 2021-03-31 | 20.26 | $2.93 | 6.91 |
| 2020-12-31 | 17.90 | $3.03 | 5.90 |
| 2020-09-30 | 11.63 | $3.03 | 3.83 |
| 2020-06-30 | 9.24 | $2.99 | 3.09 |
| 2020-03-31 | 10.40 | $3.13 | 3.33 |
| 2019-12-31 | 17.89 | $3.34 | 5.36 |
| 2019-09-30 | 12.48 | $3.43 | 3.64 |
| 2019-06-30 | 19.80 | $3.51 | 5.63 |
| 2019-03-31 | 21.06 | $3.60 | 5.86 |
| 2018-12-31 | 20.43 | $3.78 | 5.41 |
| 2018-09-30 | 36.85 | $3.87 | 9.53 |
| 2018-06-30 | 50.25 | $3.93 | 12.79 |
| 2018-03-31 | 36.50 | $0.63 | 58.33 |
| 2017-12-31 | 28.30 | $0.73 | 38.60 |
| 2017-09-30 | 19.35 | $0.32 | 61.23 |
| 2017-06-30 | 16.75 | $0.34 | 49.15 |
| 2017-03-31 | 10.45 | $0.37 | 28.50 |
| 2016-12-31 | 9.00 | $0.45 | 19.91 |
| 2016-09-30 | 9.03 | $0.04 | 247.40 |
| 2016-06-30 | 6.88 | $0.09 | 74.22 |
| 2016-03-31 | 5.36 | $0.16 | 33.27 |
| 2015-12-31 | 5.00 | $0.27 | 18.29 |
| 2015-09-30 | 4.12 | $0.37 | 11.00 |
| 2015-06-30 | 3.14 | $-0.14 | -22.18 |
| 2015-03-31 | 3.50 | $-0.03 | -128.21 |
| 2014-12-31 | 3.59 | $-0.58 | -6.22 |
| 2014-09-30 | 2.44 | $-0.58 | -4.18 |
| 2014-06-30 | 2.78 | $-0.41 | -6.77 |
| 2014-03-31 | 3.05 | $-0.21 | -14.41 |
| 2013-12-31 | 4.49 | $0.01 | 568.35 |
| 2013-09-30 | 4.44 | $0.24 | 18.71 |
| 2013-06-30 | 4.34 | $-0.83 | -5.20 |
| 2013-03-31 | 3.61 | $-0.54 | -6.69 |
| 2012-12-31 | 2.70 | $-0.25 | -10.61 |
| 2012-09-30 | 2.70 | $0.11 | 24.88 |
| 2012-06-30 | 3.00 | $0.29 | 10.19 |
| 2012-03-31 | 2.70 | $0.37 | 7.25 |
| 2011-12-31 | 2.70 | $0.55 | 4.92 |
| 2011-09-30 | 2.50 | $0.73 | 3.44 |
| 2011-06-30 | 3.00 | $2.68 | 1.12 |
| 2011-03-31 | 2.75 | $2.59 | 1.06 |
| 2010-12-31 | 3.49 | $-9.70 | -0.36 |
| 2010-09-30 | 3.50 | $2.38 | 1.47 |
| 2010-06-30 | 2.99 | $2.47 | 1.21 |
| 2010-03-31 | 3.10 | $2.52 | 1.23 |
| 2009-12-31 | 3.38 | $2.58 | 1.31 |
| 2009-09-30 | 3.74 | $0.04 | 86.09 |
| 2009-06-30 | 2.95 | $0.07 | 39.75 |
| 2009-03-31 | 4.00 | $0.04 | 95.86 |
| 2008-12-31 | 2.31 | $0.07 | 31.70 |
| 2008-09-30 | 3.58 | $0.10 | 35.34 |
| 2008-06-30 | 1.98 | $0.13 | 15.11 |
| 2008-03-31 | 1.48 | $0.17 | 8.60 |
| 2007-12-31 | 1.09 | $0.22 | 5.08 |
| 2007-09-30 | 2.40 | $0.22 | 10.91 |
| 2007-06-30 | 4.04 | $0.25 | 16.27 |
| 2007-03-31 | 0.59 | $0.29 | 2.07 |
| 2006-12-31 | 0.55 | $0.31 | 1.75 |
| 2006-09-30 | 0.21 | $0.35 | 0.60 |
| 2006-06-30 | 0.29 | $0.36 | 0.81 |
| 2006-03-31 | 0.49 | $0.39 | 1.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.564B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $198.062B | 23.05 |
| Intuitive Surgical (ISRG) | United States | $176.187B | 67.96 |
| IDEXX Laboratories (IDXX) | United States | $51.802B | 49.63 |
| Edwards Lifesciences (EW) | United States | $46.035B | 30.99 |
| Alcon (ALC) | Switzerland | $39.268B | 26.46 |
| IQVIA Holdings (IQV) | United States | $30.174B | 16.30 |
| Mettler-Toledo (MTD) | United States | $28.306B | 32.55 |
| DexCom (DXCM) | United States | $26.580B | 36.64 |
| STERIS (STE) | Ireland | $23.878B | 24.15 |
| Waters (WAT) | United States | $19.603B | 25.07 |
| Coloplast (CLPBY) | Denmark | $17.488B | 26.76 |
| Hologic (HOLX) | United States | $16.763B | 17.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.540B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.942B | 11.56 |
| Penumbra (PEN) | United States | $13.247B | 93.18 |
| Globus Medical (GMED) | United States | $11.813B | 24.79 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.254B | 23.24 |
| Sysmex ADR (SSMXY) | Japan | $6.295B | 20.00 |
| Glaukos (GKOS) | United States | $6.262B | 0.00 |
| Teleflex (TFX) | United States | $4.727B | 7.53 |
| TransMedics (TMDX) | United States | $4.555B | 53.97 |
| LivaNova (LIVN) | United Kingdom | $3.627B | 19.60 |
| Integer Holdings (ITGR) | United States | $3.055B | 14.34 |
| Veracyte (VCYT) | United States | $2.845B | 32.42 |
| Elekta AB (EKTAY) | Sweden | $2.250B | 21.05 |
| Nihon Kohden (NHNKY) | Japan | $2.036B | 22.47 |
| UFP Technologies (UFPT) | United States | $2.032B | 26.83 |
| Alphatec Holdings (ATEC) | United States | $2.001B | 0.00 |
| Artivion (AORT) | United States | $1.900B | 87.17 |
| Pulse Biosciences (PLSE) | United States | $1.711B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.593B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.333B | 0.00 |
| IRadimed (IRMD) | United States | $1.311B | 58.90 |
| OPKO Health (OPK) | United States | $0.960B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.871B | 4.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.702B | 14.00 |
| SiBone (SIBN) | United States | $0.661B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.632B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.617B | 35.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.13 |
| NeuroPace (NPCE) | United States | $0.485B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.469B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.335B | 55.88 |
| RxSight (RXST) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.236B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.129B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.127B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| Solana (HSDT) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |